FDA approves expanded use of Emergent BioSolution's anthrax vaccine

(Reuters) - The U.S. Food and Drug Administration approved to expand the use of Emergent BioSolutions Inc's anthrax vaccine to prevent suspected or confirmed exposure to the bacterium that causes the disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news